Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes

6 Mar 2015

Abstract excerpt

Research has provided evidence for immune surveillance in patients with myelodysplastic syndromes (MDS). However, while the presence of immune surveillance in MDS has been observed, little is known about its prognostic implications. This study aimed to identify the prognostic impact of an immune

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Immune cells in cancer
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25749828
DOI: 10.3324/haematol.2014.116657

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromesPMID 25749828Read ↗

Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromesSemantic proximity Read ↗

Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndromeSemantic proximity Read ↗

The Role of the Immune System in Myelodysplasia: Implications for TherapySemantic proximity Read ↗

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMTSemantic proximity Read ↗

Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome.Semantic proximity Read ↗

The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.Semantic proximity Read ↗

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsSemantic proximity Read ↗

Evaluating the prognosis of patients with myelodysplastic syndromes.Semantic proximity Read ↗

Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression.Semantic proximity Read ↗

VISTA mediates the progression of myelodysplastic syndromeSemantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

Clonal hematopoiesis and differential outcomes after immune checkpoint blockadeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.